Status:
COMPLETED
Comparative Bioavailability Study of Azithromycin 200mg/5mL Suspension Following a 600mg Dose Under Fed Conditions
Lead Sponsor:
Sandoz
Conditions:
Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to demonstrate the bioequivalence of Azithromycin 200mg/5mL oral suspension.
Eligibility Criteria
Inclusion
- No clinically significant findings on physical exam, medial history or laboratory tests on screening
Exclusion
- Positive test for HIV or hepatitis B and C
- Treatment for Drug or alcohol abuse
- Any other important criteria in the protocol
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2004
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT00875966
Start Date
August 1 2004
End Date
October 1 2004
Last Update
March 29 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.